Testing effectiveness (Phase 2)Study completedNCT01301898
What this trial is testing
To Evaluate the Safety and Efficacy of GC1111 (Recombinant Human Iduronate-2-sulfatase) in Hunter Syndrome Patients
Who this might be right for
Mucopolysaccharidosis II
Green Cross Corporation 31